These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31104927)

  • 1. Assessment of the relationship between preprocedural C-reactive protein/albumin ratio and stent restenosis in patients with ST-segment elevation myocardial infarction.
    Rencuzogullari I; Karabağ Y; Çağdaş M; Karakoyun S; Seyis S; Gürsoy MO; Yesin M; Artaç İ; İliş D; Tanboğa İH
    Rev Port Cardiol (Engl Ed); 2019 Apr; 38(4):269-277. PubMed ID: 31104927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C-Reactive Protein to Albumin Ratio Predicts Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Karabağ Y; Çağdaş M; Rencuzogullari I; Karakoyun S; Artaç İ; İliş D; Yesin M; Çiftçi H; Erdoğdu HI; Tanboğa IH
    Heart Lung Circ; 2019 Nov; 28(11):1638-1645. PubMed ID: 30293924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between CRP / Albumin ratio and in-stent restenosis development in patients with ST-segment elevation myocardial infarction.
    Aksu U; Gulcu O; Aksakal E; Kalkan K; Öztürk M; Korkmaz AF; Uslu A; Demirelli S
    J Clin Lab Anal; 2019 May; 33(4):e22848. PubMed ID: 30737841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of The C-Reactive Protein/Albumin Ratio for Predicting No-Reflow in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Karabağ Y; Çağdaş M; Rencuzogullari I; Karakoyun S; Artaç İ; İliş D; Yesin M; Çağdaş ÖS; Altıntaş B; Burak C; Tanboğa HI
    Eur J Clin Invest; 2018 Jun; 48(6):e12928. PubMed ID: 29577260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preprocedural C-Reactive Protein Predicts Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-elevation Myocardial Infarction a systematic meta-analysis.
    Mincu RI; Jánosi RA; Vinereanu D; Rassaf T; Totzeck M
    Sci Rep; 2017 Jan; 7():41530. PubMed ID: 28128312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis.
    Yılmaz S; Sen F; Ünal S; Yayla C; Özeke Ö; Aras D; Topaloglu S; Aydogdu S
    Scand Cardiovasc J; 2015 Feb; 49(1):39-44. PubMed ID: 25414124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of high level of hs-CRP with in-stent restenosis: A case-control study.
    Baktashian M; Saffar Soflaei S; Kosari N; Salehi M; Khosravi A; Ahmadinejad M; Moohebati M; Ebrahimi M; Rahmani F; Khameneh-Bagheri R; Ahmadi M; Sadabadi F; Tayefi M; Bazhdanzadeh S; Ferns GA; Hashemi SM; Pasdar A; Ghayour-Mobarhan M
    Cardiovasc Revasc Med; 2019 Jul; 20(7):583-587. PubMed ID: 30232022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neutrophil-to-lymphocyte ratio is associated with bare-metal stent restenosis in STEMI patients treated with primary PCI.
    Bolca O; Güngör B; Özcan KS; Karadeniz FÖ; Sungur A; Köroğlu B; Bakhshyaliyev N; Yelgeç NS; Karataş B; İpek G; Yilmaz H; Öztürk R
    Coron Artery Dis; 2015 Aug; 26(5):402-8. PubMed ID: 25919903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between RDW and stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Tunçez A; Çetin MS; Çetin EHÖ; Yilmaz S; Korkmaz A; Uçar FM
    Medicine (Baltimore); 2017 Feb; 96(5):e5986. PubMed ID: 28151892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction.
    Çınar T; Çağdaş M; Rencüzoğulları İ; Karakoyun S; Karabağ Y; Yesin M; Sadioğlu Çağdaş Ö; Tanboğa Hİ
    Scand Cardiovasc J; 2019 Apr; 53(2):83-90. PubMed ID: 30835559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.
    Turak O; Canpolat U; Özcan F; Mendi MA; Oksüz F; Işleyen A; Gürel OM; Çay S; Aras D; Aydoğdu S
    Am J Cardiol; 2014 Jan; 113(2):197-202. PubMed ID: 24157191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
    Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement.
    Rittersma SZ; de Winter RJ; Koch KT; Schotborgh CE; Bax M; Heyde GS; van Straalen JP; Mulder KJ; Tijssen JG; Sanders GT; Piek JJ
    Clin Chem; 2004 Sep; 50(9):1589-96. PubMed ID: 15205368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High red blood cell distribution width is closely associated with in-stent restenosis in patients with unstable angina pectoris.
    Geng N; Su G; Wang S; Zou D; Pang W; Sun Y
    BMC Cardiovasc Disord; 2019 Jul; 19(1):175. PubMed ID: 31340761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of admission red cell distribution width-to-platelet ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Pusuroglu H; Cakmak HA; Akgul O; Erturk M; Surgit O; Akkaya E; Bulut U; Yildirim A
    Rev Port Cardiol; 2015 Oct; 34(10):597-606. PubMed ID: 26387826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein velocity and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
    Zahler D; Rozenfeld KL; Stein M; Milwidsky A; Berliner S; Banai S; Arbel Y; Shacham Y
    J Nephrol; 2019 Jun; 32(3):437-443. PubMed ID: 30706372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cell distribution width in coronary heart disease: prediction of restenosis and its relationship with inflammatory markers and lipids.
    Qian H; Luo Z; Xiao C; Chen J; Li D; Xu H; He P; Zhou X; Zhang T; Min X
    Postgrad Med J; 2018 Sep; 94(1115):489-494. PubMed ID: 30301834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
    Zurakowski A; Wojakowski W; Dzielski T; Milewski K; Gościńska-Bis K; Tendera M; Buszman P
    Kardiol Pol; 2009 Jun; 67(6):623-30. PubMed ID: 19618318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An elevated value of C-reactive protein is the only predictive factor of restenosis after percutaneous coronary intervention.
    Jeong WK; Jeong MH; Kim KH; Lee SR; Park OY; Yum JH; Kim JH; Kim W; Rhew JY; Ahn YK; Cho JG; Ahn BH; Suh SP; Park JC; Kim SH; Kang JC
    Korean J Intern Med; 2003 Sep; 18(3):154-60. PubMed ID: 14619384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.